RS-virus

Ares-Gómez, S., Mallah, N., Santiago-Pérez, M.-I., Pardo-Seco, J., Pérez-Martínez, O., Otero-Barrós, M.-T., Suárez-Gaiche, N., Kramer, R., Jin, J., Platero-Alonso, L., Alvárez-Gil, R.-M., Ces-Ozores, O.-M., Nartallo-Penas, V., Mirás-Carballal, S., Piñeiro-Sotelo, M., Malvar-Pintos, A., González-Pérez, J.-M., Rodríguez-Tenreiro-Sánchez, C., Rivero-Calle, I., … Martinón-Torres, F. (2024). Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. The Lancet Infectious Diseases, 24(8), 817–828. https://doi.org/10.1016/S1473-3099(24)00215-9 AstraZeneca. (1999). Synagis 100 mg/ml [SmPC]. https://www.ema.europa.eu/nl/documents/product-information/synagis-epar-product-information_nl.pdf Banoun, H. (2024). Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention. Current Issues in Molecular Biology, 46(9), 10369–10395. https://doi.org/10.3390/cimb46090617 Bar-Yoseph, R., Haddad, J., Hanna, M., Kessel, I., Kugelman, A., Hakim, F., & Bentur, L. (2019). Long term follow-up of Palivizumab administration in children born at 29-32 weeks  of gestation. Respiratory Medicine, 150, 149–153. https://doi.org/10.1016/j.rmed.2019.03.001 Beigelman, A., Castro, M., Schweiger, T. L., Wilson, B. S., Zheng, J., Yin-DeClue, H., Sajol, G., Giri, T., Sierra, O. L., Isaacson-Schmid, M., Sumino, K., Schechtman, K. B., & Bacharier, L. B. (2015). Vitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus  Bronchiolitis Among Hospitalized Infants. Journal of the Pediatric Infectious Diseases Society, 4(3), 182–188. https://doi.org/10.1093/jpids/piu042 Belderbos, M. E., Houben, M. L., Wilbrink, B., Lentjes, E., Bloemen, E. M., Kimpen, J. L. L., Rovers, M., & Bont, L. (2011). Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics, 127(6). https://doi.org/10.1542/peds.2010-3054 Black, C. P. (2003). Systematic review of the biology and medical management of respiratory syncytial virus infection. Respiratory Care, 48(3), 209–231. Borchers, A. T., Chang, C., Gershwin, M. E., & Gershwin, L. J. (2013). Respiratory syncytial virus - A comprehensive review. Clinical Reviews in Allergy and Immunology, 45(3), 331–379. https://doi.org/10.1007/s12016-013-8368-9 Boyce, T. G., Mellen, B. G., Mitchel, E. F. J., Wright, P. F., & Griffin, M. R. (2000). Rates of hospitalization for respiratory syncytial virus infection among children  in medicaid. The Journal of Pediatrics, 137(6), 865–870. https://doi.org/10.1067/mpd.2000.110531 Connor, E. M. (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 102(3 I), 531–537. https://doi.org/10.1542/peds.102.3.531 Coultas, J. A., Smyth, R., & Openshaw, P. J. (2019). Respiratory syncytial virus (RSV): a scourge from infancy to old age. Thorax, 74(10), 986–993. https://doi.org/10.1136/thoraxjnl-2018-212212 Dagan, R., Hammitt, L. L., Nuñez, B. S., Cots, M. B., Bosheva, M., Madhi, S. A., Muller, W. J., Zar, H. J., Chang, Y., Currie, A., Grenham, A., Shroff, M., Takas, T., Mankad, V. S., Leach, A., & Villafana, T. (2024). Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season. Journal of the Pediatric Infectious Diseases Society, 13(2), 144–147. https://doi.org/10.1093/jpids/piad113 Deng, S., Cong, B., Edgoose, M., De Wit, F., Nair, H., & Li, Y. (2024). Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis. International Journal of Infectious Diseases, 146, 107125. https://doi.org/10.1016/j.ijid.2024.107125 Dieussaert, I., Hyung Kim, J., Luik, S., Seidl, C., Pu, W., Stegmann, J.-U., Swamy, G. K., Webster, P., & Dormitzer, P. R. (2024). RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes. New England Journal of Medicine, 390(11), 1009–1021. https://doi.org/10.1056/nejmoa2305478 Drysdale, S. B., Cathie, K., Flamein, F., Knuf, M., Collins, A. M., Hill, H. C., Kaiser, F., Cohen, R., Pinquier, D., Felter, C. T., Vassilouthis, N. C., Jin, J., Bangert, M., Mari, K., Nteene, R., Wague, S., Roberts, M., Tissières, P., Royal, S., & Faust, S. N. (2023). Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. New England Journal of Medicine, 389(26), 2425–2435. https://doi.org/10.1056/nejmoa2309189 EMA. (2022). EPAR Assessment report Beyfortus (Procedure No. EMEA/H/C.005304/0000). Eriksson, M., Bennet, R., Rotzén-Ostlund, M., von Sydow, M., & Wirgart, B. Z. (2002). Population-based rates of severe respiratory syncytial virus infection in  children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatrica (Oslo, Norway : 1992), 91(5), 593–598. https://doi.org/10.1080/080352502753711740 Ferolla, F. M., Yfran, E. W., Ballerini, M. G., Caratozzolo, A., Toledano, A., Giordano, A. C., Acosta, P. L., Cassinelli, H., Bergada, I., Ropelato, M. G., Contrini, M. M., & López, E. L. (2022). Serum Vitamin D Levels and Life-Threatening Respiratory Syncytial Virus Infection  in Previously Healthy Infants. The Journal of Infectious Diseases, 226(6), 958–966. https://doi.org/10.1093/infdis/jiac033 Fortmann, I., Dammann, M.-T., Humberg, A., Kraft, H., Herz, A., Hanke, K., Faust, K., Ricklefs, I., Zemlin, M., Liese, J., Engels, G., Härtel, C., Fortmann-Grote, C., Kopp, M. V., Brinkmann, F., Herting, E., Göpel, W., & Stichtenoth, G. (2024). Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age. CHEST Pulmonary, 2(1). https://doi.org/10.1016/j.chpulm.2023.100026 Francese, R., Peila, C., Donalisio, M., Lamberti, C., Cirrincione, S., Colombi, N., Tonetto, P., Cavallarin, L., Bertino, E., Moro, G. E., Coscia, A., & Lembo, D. (2023). Viruses and Human Milk: Transmission or Protection? Advances in Nutrition, 14(6), 1389–1415. https://doi.org/10.1016/j.advnut.2023.08.007 Garegnani, L., Styrmisdóttir, L., Roson Rodriguez, P., Escobar Liquitay, C. M., Esteban, I., & Franco, J. V. A. (2021). Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews, 2021(11). https://doi.org/10.1002/14651858.CD013757.pub2 Gezondheidsraad. (2024). Immunisatie tegen RSV in het eerste levensjaar. https://www.gezondheidsraad.nl/onderwerpen/vaccinaties/alle-adviezen-over-vaccinaties/immunisatie-tegen-rsv-in-het-eerste-levensjaar Griffin, M. P., Yuan, Y., Takas, T., Domachowske, J. B., Madhi, S. A., Manzoni, P., Simões, E. A. F., Esser, M. T., Khan, A. A., Dubovsky, F., Villafana, T., & DeVincenzo, J. P. (2020). Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. New England Journal of Medicine, 383(5), 415–425. https://doi.org/10.1056/nejmoa1913556 Hammitt, L. L., Dagan, R., Yuan, Y., Baca Cots, M., Bosheva, M., Madhi, S. A., Muller, W. J., Zar, H. J., Brooks, D., Grenham, A., Wählby Hamrén, U., Mankad, V. S., Ren, P., Takas, T., Abram, M. E., Leach, A., Griffin, M. P., & Villafana, T. (2022). Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. New England Journal of Medicine, 386(9), 837–846. https://doi.org/10.1056/nejmoa2110275 Hanson, L. A. (2004). Immunobiology of Human Milk (p. 240). Hogan, C. A., Caya, C., & Papenburg, J. (2018). Rapid and simple molecular tests for the detection of respiratory syncytial virus: a review. Expert Review of Molecular Diagnostics, 18(7), 617–629. https://doi.org/10.1080/14737159.2018.1487293 Hurwitz, J. L. (2011). Respiratory syncytial virus vaccine development. Expert Review of Vaccines, 10(10), 1415–1433. https://doi.org/10.1586/erv.11.120 Kampmann, B., Madhi, S. A., Munjal, I., Simões, E. A. F., Pahud, B. A., Llapur, C., Baker, J., Pérez Marc, G., Radley, D., Shittu, E., Glanternik, J., Snaggs, H., Baber, J., Zachariah, P., Barnabas, S. L., Fausett, M., Adam, T., Perreras, N., Van Houten, M. A., … Gurtman, A. (2023). Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. New England Journal of Medicine, 388(16), 1451–1464. https://doi.org/10.1056/nejmoa2216480 Karatekin, G., Kaya, A., Salihoğlu, O., Balci, H., & Nuhoğlu, A. (2009). Association of subclinical vitamin D deficiency in newborns with acute lower  respiratory infection and their mothers. European Journal of Clinical Nutrition, 63(4), 473–477. https://doi.org/10.1038/sj.ejcn.1602960 Lanari, M., Prinelli, F., Adorni, F., Di Santo, S., Faldella, G., Silvestri, M., & Musicco, M. (2013). Maternal milk protects infants against bronchiolitis during the first year of life: Results from an Italian cohort of newborns. Early Human Development, 89(SUPPL.1), S51–S57. https://doi.org/10.1016/S0378-3782(13)70016-1 Landelijke Coördinatie Infectieziektebestrijding. (2025). RSV-infectie | LCI-richtlijn. https://lci.rivm.nl/richtlijnen/rsv-infectie Li, Y., Hodgson, D., Wang, X., Atkins, K. E., Feikin, D. R., & Nair, H. (2021). Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. The Lancet Infectious Diseases, 21(9), 1303–1312. https://doi.org/10.1016/S1473-3099(20)30703-9 Madhi, S. A., Kampmann, B., Simões, E. A. F., Zachariah, P., Pahud, B. A., Radley, D., Sarwar, U. N., Shittu, E., Llapur, C., Pérez Marc, G., Maldonado, Y., Kachikis, A., Zar, H. J., Swanson, K. A., Lino, M. M., Anderson, A. S., Gurtman, A., & Munjal, I. (2025). Preterm Birth Frequency and Associated Outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstetrics and Gynecology, 145(2), 147–156. https://doi.org/10.1097/AOG.0000000000005817 Mazur, N. I., Löwensteyn, Y. N., Terstappen, J., Leusen, J., Schobben, F., Cianci, D., van de Ven, P. M., Nierkens, S., Bont, L. J., Nibbelke, E. E., Buiteman, B., Rave, N., Putten, M. V., Smit-Kleinlugtenbeld, E. A., de Lege-Korstanje, J. P., Peetsold, M. G., Hulsmann, A., van Gool, S., Snepvangers, Y., … Schuurman, R. (2023). Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial. EClinicalMedicine, 66. https://doi.org/10.1016/j.eclinm.2023.102324 McNally, J. D., Leis, K., Matheson, L. A., Karuananyake, C., Sankaran, K., & Rosenberg, A. M. (2009). Vitamin D deficiency in young children with severe acute lower respiratory  infection. Pediatric Pulmonology, 44(10), 981–988. https://doi.org/10.1002/ppul.21089 MHRA Drug Safety Update. (2025). Drug Safety Update Abrysvo and Arexvy. 18(12). Mineva, G. M., Purtill, H., Dunne, C. P., & Philip, R. K. (2023). Impact of breastfeeding on the incidence and severity of respiratory syncytial virus (RSV)-associated acute lower respiratory infections in infants: a systematic review highlighting the global relevance of primary prevention. BMJ Global Health, 8(2). https://doi.org/10.1136/bmjgh-2022-009693 Muller, W. J., Madhi, S. A., Seoane Nuñez, B., Baca Cots, M., Bosheva, M., Dagan, R., Hammitt, L. L., Llapur, C. J., Novoa, J. M., Saez Llorens, X., Grenham, A., Kelly, E. J., Mankad, V. S., Shroff, M., Takas, T., Leach, A., & Villafana, T. (2023). Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants. New England Journal of Medicine, 388(16), 1533–1534. https://doi.org/10.1056/nejmc2214773 Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O’Brien, K. L., Roca, A., Wright, P. F., Bruce, N., Chandran, A., Theodoratou, E., Sutanto, A., Sedyaningsih, E. R., Ngama, M., Munywoki, P. K., Kartasasmita, C., Simões, E. A., Rudan, I., … Campbell, H. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. The Lancet, 375(9725), 1545–1555. https://doi.org/10.1016/S0140-6736(10)60206-1 O’hagan, S., Galway, N., Shields, M. D., Mallett, P., & Groves, H. E. (2023). Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease. Drug, Healthcare and Patient Safety, 15(September), 103–112. https://doi.org/10.2147/DHPS.S348727 Orsi, A., Scarpaleggia, M., Baldo, V., Barbone, F., Chironna, M., Giuffrida, S., Montomoli, E., Pariani, E., Rizzo, C., Panatto, D., & Icardi, G. (2024). First real-world data on universal respiratory syncytial virus prophylaxis with  Nirsevimab in infants. Journal of Preventive Medicine and Hygiene, 65(2), E172–E187. https://doi.org/10.15167/2421-4248/jpmh2024.65.2.3329 Prais, D., Kaplan, E., Klinger, G., Mussaffi, H., Mei-Zahav, M., Bar-Yishay, E., Stafler, P., Steuer, G., Sirota, L., & Blau, H. (2016). Short- and Long-term Pulmonary Outcome of Palivizumab in Children Born Extremely Prematurely. Chest, 149(3), 801–808. https://doi.org/https://doi.org/10.1378/chest.15-0328 Puccio, G., Alliet, P., Cajozzo, C., Janssens, E., Corsello, G., Sprenger, N., Wernimont, S., Egli, D., Gosoniu, L., & Steenhout, P. (2017). Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity. Journal of Pediatric Gastroenterology and Nutrition, 64(4), 624–631. https://doi.org/https://doi.org/10.1097/MPG.0000000000001520 Regeling zorgverzekering. (2016). https://wetten.overheid.nl/BWBR0018715/ Roth, D. E., Jones, A. B., Prosser, C., Robinson, J. L., & Vohra, S. (2009). Vitamin D status is not associated with the risk of hospitalization for acute  bronchiolitis in early childhood. European Journal of Clinical Nutrition, 63(2), 297–299. https://doi.org/10.1038/sj.ejcn.1602946 Roth, D. E., Shah, R., Black, R. E., & Baqui, A. H. (2010). Vitamin D status and acute lower respiratory infection in early childhood in  Sylhet, Bangladesh. Acta Paediatrica (Oslo, Norway : 1992), 99(3), 389–393. https://doi.org/10.1111/j.1651-2227.2009.01594.x Simões, E. A. F., Madhi, S. A., Muller, W. J., Atanasova, V., Bosheva, M., Cabañas, F., Baca Cots, M., Domachowske, J. B., Garcia-Garcia, M. L., Grantina, I., Nguyen, K. A., Zar, H. J., Berglind, A., Cummings, C., Griffin, M. P., Takas, T., Yuan, Y., Wählby Hamrén, U., Leach, A., & Villafana, T. (2023). Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised. The Lancet Child and Adolescent Health, 7(3), 180–189. https://doi.org/10.1016/S2352-4642(22)00321-2 Simões, E. A. F., Pahud, B. A., Madhi, S. A., Kampmann, B., Shittu, E., Radley, D., Llapur, C., Baker, J., Pérez Marc, G., Barnabas, S. L., Fausett, M., Adam, T., Perreras, N., Van Houten, M. A., Kantele, A., Huang, L. M., Bont, L. J., Otsuki, T., Vargas, S. L., … Munjal, I. (2025). Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstetrics and Gynecology, 145(2), 157–167. https://doi.org/10.1097/AOG.0000000000005816 Snape, M. D., Moore, J., Du, J., Reuter, C., Penn, N., Stoszek, S. K., & Shaw, C. A. (2024). Safety and Immunogenicity of an mRNA-Based Rsv Vaccine and an Rsv/hMPV Combination Vaccine in Children 5 to 23 Months of Age. Preprints. https://doi.org/10.20944/preprints202412.0878.v1 Son, M., Riley, L. E., Staniczenko, A. P., Cron, J., Yen, S., Thomas, C., Sholle, E., Osborne, L. M., & Lipkind, H. S. (2024). Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes. JAMA Network Open, 7(7), e2419268–e2419268. https://doi.org/10.1001/jamanetworkopen.2024.19268 Sumsuzzman, D. M., Wang, Z., Langley, J. M., & Moghadas, S. M. (2025). Real-world effectiveness of nirsevimab against respiratory syncytial virus  disease in infants: a systematic review and meta-analysis. The Lancet. Child & Adolescent Health, 9(6), 393–403. https://doi.org/10.1016/S2352-4642(25)00093-8 Terstappen, J., Nibbelke, E. E., Ascough, S., Bergstrom, E., Bont, L. J., Buiteman, B. J. M., Chiu, C., Cianci, D., Dayananda, P., Delemarre, E. M., de Groot-Mijnes, J. D. F., McCall, M. B. B., Reitsma, J. B., Schuurman, R., Taylor, L., Troelstra, A., Versnel, A., Vlaskamp, J., Viveen, M., … Mazur, N. I. (2025). Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial. Npj Drug Discovery, 2(1), 15. https://doi.org/10.1038/s44386-025-00018-1 Thorburn, K., Harigopal, S., Reddy, V., Taylor, N., & van Saene, H. K. F. (2006). High incidence of pulmonary bacterial co-infection in children with severe  respiratory syncytial virus (RSV) bronchiolitis. Thorax, 61(7), 611–615. https://doi.org/10.1136/thx.2005.048397 Tonon, K. M., Chutipongtanate, S., Morrow, A. L., & Newburg, D. S. (2024). Human Milk Oligosaccharides and Respiratory Syncytial Virus Infection in Infants. Advances in Nutrition, 15(6), 100218. https://doi.org/10.1016/j.advnut.2024.100218 Vaghari-Tabari, M., Mohammadzadeh, I., Qujeq, D., Majidinia, M., Alemi, F., Younesi, S., Mahmoodpoor, A., Maleki, M., Yousefi, B., & Asemi, Z. (2023). Vitamin D in respiratory viral infections: a key immune modulator? Critical Reviews in Food Science and Nutrition, 63(14), 2231–2246. https://doi.org/10.1080/10408398.2021.1972407 Vandenplas, Y., Berger, B., Carnielli, V. P., Ksiazyk, J., Lagström, H., Sanchez Luna, M., Migacheva, N., Mosselmans, J.-M., Picaud, J.-C., Possner, M., Singhal, A., & Wabitsch, M. (2018). Human Milk Oligosaccharides: 2’-Fucosyllactose (2’-FL) and Lacto-N-Neotetraose  (LNnT) in Infant Formula. Nutrients, 10(9). https://doi.org/10.3390/nu10091161 Vereen, S., Gebretsadik, T., Hartert, T. V, Minton, P., Woodward, K., Liu, Z., & Carroll, K. N. (2014). Association Between Breast-Feeding and Severity of Acute Viral Respiratory Tract Infection. The Pediatric Infectious Disease Journal, 33(9). https://journals.lww.com/pidj/fulltext/2014/09000/association_between_breast_feeding_and_severity_of.25.aspx Voedingscentrum. (n.d.). Vitamine D. Wang, Q., Xu, M., Wang, Y., & Yu, H. (2023). 916. The Transfer of Maternal Antibodies and Dynamics of Maternal and Natural Infection-induced Antibodies against RSV in Children: A Longitudinal Cohort Study. Open Forum Infectious Diseases, 10(Supplement_2), ofad500.961. https://doi.org/10.1093/ofid/ofad500.961